Company Active LTD

Company profile

Hybrisan Ltd

UK company 08663730, incorporated on 27 August 2013.

Hybrisan | Innovators in Infection Control

Hybrisan is a MedTech company founded to revolutionise wound care through the development of our unique WoundSan technology.

Company number
08663730
Incorporated
27 Aug 2013
Companies House status
Active

Company identity

Founded / incorporated
27 August 2013

Company number 08663730

Verify at Companies House
Legal name
HYBRISAN LTD
Company type
Private Limited Company
Region
West Midlands
Registered address
SUITE A
WHITESTONE BUSINESS PARK
HEREFORD
ENGLAND
HR1 3SE
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

05 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

19 Jun
2026

Change Account Reference Date Company Current Extended

Accounts Analysed

AA01 | Transaction MzUyNzM3MTc0OGFkaXF6a2N4

Published 19 Jun 2026 16:03

31 Aug
2025

Accounts filed

Accounts

Last accounts made up date

22 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

27 Aug
2013

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020, 2022
Age at first award
6 years

Projects

2022 Collaborative R&D Lead participant

Healing the Gap in Wound Technology

1 Oct 2022 to 30 Sep 2023

Awarded
£205,681
Total cost £374,579

There is an urgent need for innovate products in the chronic wound care market due to an increasing prevalence of chronic wounds and a lack of confidence in existing technologies. There were an estimated 3.8 million patients with a wound managed by the NHS in 2017/18 with an increase in prevalence of 71% between 2012/13 and 2017/18\. There are several ant...

2020 Feasibility Studies Lead participant

Changing the face of facemasks

1 Jun 2020 to 30 Nov 2020

Awarded
£49,311
Total cost £49,311

Covid-19 has created a shortage of anti-viral products such as sanitisers and Personal Protective Equipment (PPE). This is both a short-term issue -- to cope with a huge increase in demand -- and a long-term issue as the crisis has exposed the fragility of international supply chains. Hybrisan has developed a biocidal electrospun nonwoven material than ca...

Product types

Collaborative R&D Feasibility Studies